Home > Boards > US Listed > Biotechs >

Amarin Corp. PLC ADS (AMRN)

AMRN RSS Feed
Add AMRN Price Alert      Hide Sticky   Hide Intro
Moderator: ziploc_1, massulo52, zmanindc, marzan, iryokabu, Number sleven
Search This Board: 
Last Post: 12/8/2021 9:19:52 PM - Followers: 1055 - Board type: Free - Posts Today: 111

AMARIN TICKER RELATED LINKS
Amarin Webpage
NASDAQ AMRN Quote 
Y! Finance AMRN Landing Page 
Seeking Alpha AMRN Landing Page
FinViz AMRN Landing Page


VASCEPA RELATED LINKS & Outside Organizational News
The EPA Drug Initiative (EPADI)
Vascepa Savings Card Program
FDA Orange Book entry for Vascepa
Vascepa Prescribing Information
Vascepa Marine DTC Patient Brochure
Nissui EPA Synthesis History & Methodology
FDA Approval of Vascepa for the Reduction of Triglyceride Levels ≥ 500mg/dL (26 Jul 2012)
Pure EPA Vascepa Now Available in Half-Gram Capsule Size (25 Oct 2016)
ADA’s 2019 Standards of Medical Care in Diabetes Incorporate Findings from REDUCE-IT (28 Mar 2019)
New 2019 Updates to the European Society of Cardiology and European Atherosclerosis Society’s Guidelines incorporate Reduce-IT (3 Sep 2019)
National Lipid Association’s New Position Statement on Use of Icosapent Ethyl (16 Sep 2019)
Independent Drug-Pricing Assessment Finds Vascepa Cost-Effective (17 Oct 2019)

RELEVANT SOCIAL MEDIA ACCOUNTS
Amarin Instagram - @amarincorp Amarin Twitter - @amarincorp Amarin LinkedIn Amarin ADP Portal - Job Openings Dr. Bhatt Twitter - @DLBHATTMD
TerraPharma Twitter - @TerraPharma1 John Cappello Twitter - @JohnCappello RafunRafun Twitter - @ra_fun K Trivedi Twitter - @GPUWorld  
 

VASCEPA CLINICAL TRIALS + FDA Meetings
Marine & Anchor (Amarin Led)
MARINE Study meets primary endpoints(29 Nov 2010)
ANCHOR Trial meets all Primary and Secondary Endpoints (18 Apr 2011)
Additional Inflammatory Marker Data from Marine and Anchor (22 Jan 2013)
New Clinical Data Showing Significant Reductions in Apolipoprotein C-III Levels in Marine and Anchor (8 April 2013)
FDA AD-Com Outcome for Anchor sNDA (16 October 2013)
FDA delays ANCHOR sNDA (20 Dec 2013)
Presentation of MARINE and ANCHOR analyses at AHA showing significant reduction of remnant-like particle cholesterol (17 Nov 2014)
Marine & Anchor Key Summaries (2017)
Vascepa showed reductions in potentially atherogenic lipids and inflammatory markers – Anchor post-hoc (12 Mar 2018)

REDUCE-IT (Amarin Led)
NIH Clinical Trial Page
Amarin Announces Dosing of First Patient in REDUCE-IT (7 Dec 2011)
Amarin and FDA Reaffirm Concurrence on REDUCE-IT through SPA Agreement Amendment (4 Aug 2016)
Amarin Randomizes Final Patient into REDUCE-IT (31 Aug 2016)
REDUCE-IT to Continue As Planned at Recommendation of Independent Data Monitoring Committee (14 Aug 2017)
REDUCE-IT Meets Primary Endpoint (24 Sep 2018)
REDUCE-IT Displayed 25% RRR in 5-Point MACE (10 Nov 2018)
REDUCE-IT NEJM Article(3 Jan 2019)
REDUCE-IT showed 30% reduction in total Cardiovascular events (18 Mar 2019)
Amarin submits sNDA seeking new indication based on REDUCE-IT (28 Mar 2019)
FDA Grants Priority Review for Vascepa sNDA (29 May 2019)
Amarin Notified of Ad-Com Meeting Planned for Nov 2019 (8 Aug 2019)
REDUCE-IT USA-specific Results released (11 Nov 2019)
FDA AD-Com Outcome for REDUCE-IT sNDA (14 Nov 2019)
REDUCE-IT related data presented at 2019 AHA (18 Nov 2019)

Law Suits
Amarin Granted Summary Judgement against FDA seeking NCE market exclusivity (28 May 2015)
First Amendment Decision a win for Amarin & Physician Plaintiffs (7 Aug 2015)
Court Approves Proposed Settlement Terms in Amarin First Amendment Litigation (9 Mar 2016)
Amarin announces patent litigation settlement agreement with TEVA (24 May 2018)
Section Pending

PARTNERSHIPS / OVERSEAS
Amarin and Eddingpharm announce agreement for Vascepa in China (26 Feb 2015)
Amarin and HLS announce agreement for Vascepa in Canada (25 Sep 2017)
Commencement of Vascepa Clinical Development in China (17 Jan 2018)
Biologix and Amarin announce approval of Vascepa in Lebanon for patients with Triglyceride Levels ≥ 500mg/dL (21 Mar 2018)
Amarin & Mochida Announce Collaboration on Future Development of EPA-Based Drug Products and Indications (12 Jun 2018)
Biologix and Amarin announce approval of Vascepa in UAE for patients with Triglyceride Levels ≥ 500mg/dL (26 Jul 2018)
Vascepa granted Priority Review from Health Canada New Drug Submission, anticipated to be filed in April 2019 by HLS (29 Mar 2019)
HLS files New Drug Submission for Vascepa with Health Canada (29 April 2019)

PATENTS
Amarin list of Patents on Justia (h/t @Terrapharma1)

EPA Trials for other indications
Section Pending

Non-Vascepa (AMR-101) Amarin Trials
Section Pending

 

AMRN
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AMRN News: Amarin jumps after activist Sarissa discloses stake in 13-F filing 11/16/2021 05:52:48 AM
AMRN News: Amarin Reports Overview of Latest Clinical Research Evaluating VASCEPA®/VAZKEPA (Icosapent Ethyl) and Eicosapentaenoic Acid (EPA) Presented at the American Heart Association Scientific Sessions 2021 11/16/2021 02:00:00 AM
AMRN News: Amarin Reports Subgroup Data from REDUCE-IT® Highlighting Benefits of VASCEPA®/VAZKEPA (Icosapent Ethyl) in Patients with Prior Peripheral Artery Disease (PAD) Presented in Rapid Fire Oral Session Presentation at the American Heart Association Scientific 11/15/2021 11:30:00 AM
AMRN News: Amarin to Present at Two Upcoming Investor Conferences 11/11/2021 02:00:00 AM
AMRN News: Latest Research Evaluating VASCEPA®/VAZKEPA (Icosapent Ethyl) to be Presented at American Heart Association Scientific Sessions 2021 11/08/2021 02:00:00 AM
PostSubject
#337034  Sticky Note BOARD WARNING - READ : IH Admin [Shelly] 04/25/21 04:13:46 PM
#362537   Funny, Thank you. That was very helpful. Number sleven 12/08/21 09:19:52 PM
#362536   Assuming that's the opinion North referred to, it's funnygi2 12/08/21 09:15:14 PM
#362535   Very solid decision for us Bouf 12/08/21 09:13:52 PM
#362534   ggwpq, Thanks. Blurry eyes at this time of Number sleven 12/08/21 09:10:53 PM
#362533   Ns, I think north was referring to the ggwpq 12/08/21 09:02:37 PM
#362532   Funny, do you have more information? Number sleven 12/08/21 08:43:13 PM
#362531   Yesterda's CAFC decision referred to by N40000 seems funnygi2 12/08/21 08:41:27 PM
#362530   Marjac, Thanks. Number sleven 12/08/21 08:26:15 PM
#362529   ggwpq, I did. I actually used my magnifying Number sleven 12/08/21 08:24:47 PM
#362528   On Law360, the headline is "Full Fed. Circ. marjac 12/08/21 08:24:34 PM
#362527   Ns, your link shows three more faint lines ggwpq 12/08/21 08:17:22 PM
#362526   Laser focus Marjac Enter le MeowMeow Meowza 12/08/21 08:09:09 PM
#362525   OT. Hey sign me up for the rosemountbomber 12/08/21 08:07:30 PM
#362524   ggwpq, The first line I see in the Number sleven 12/08/21 08:01:50 PM
#362523   ggwpq, Thanks. I couldn't access the full article. Number sleven 12/08/21 07:48:09 PM
#362522   Ns, your linked article's headline said GSK has ggwpq 12/08/21 07:02:27 PM
#362521   ggwpq, I posted the headline from an article Number sleven 12/08/21 06:40:11 PM
#362520   Dream panel for marjac's case: ggwpq 12/08/21 06:35:01 PM
#362519   Laser focus Marjac. Thank you!!! Biobillionair 12/08/21 06:24:33 PM
#362518   north, "yesterday’s opinion from CAFC" on what subject? TIA. ggwpq 12/08/21 06:18:22 PM
#362517   North, I am looking for it. Based on Number sleven 12/08/21 06:17:21 PM
#362516   Read yesterday’s opinion from CAFC. north40000 12/08/21 06:13:15 PM
#362515   bolio, I believe it should be soon. I lizzy241 12/08/21 06:13:12 PM
#362513   https://www.law360.com/articles/1446435/full-fed-circ-told-teva-overreacting-in- Number sleven 12/08/21 05:13:07 PM
#362512   We were supposed to hear about China this Bolio98 12/08/21 05:12:24 PM
#362511   “Among these funds, Baker Bros. Advisors held the rosemountbomber 12/08/21 03:52:56 PM
#362510   Kiwi, Thanks. Number sleven 12/08/21 03:49:53 PM
#362509   N7. in case you were wondering what the Whalatane 12/08/21 03:47:14 PM
#362507   Kiwi, I already did based on one of Number sleven 12/08/21 03:34:50 PM
#362506   Dave thx for the detail Whalatane 12/08/21 03:32:26 PM
#362505   N7. If you're looking at wet -AMD Whalatane 12/08/21 03:28:46 PM
#362504   I see traders are writing puts. That seems The Canes 12/08/21 03:26:36 PM
#362503   Amazon has been out of OMEGAVIA for a L0tsaluck2000 12/08/21 03:22:09 PM
#362502   Kiwi, Never had angio or stents. antibluechip 12/08/21 03:19:04 PM
#362501   Kiwi, I agree. I have a position in Number sleven 12/08/21 03:15:19 PM
#362500   canes, lizzy241 12/08/21 03:12:05 PM
#362499   Thx for the detail Whalatane 12/08/21 03:10:54 PM
#362498   rose, This Virus have turned World upside down jasbg 12/08/21 03:06:55 PM
#362497   N7. Re your other question Whalatane 12/08/21 03:02:25 PM
#362496   Kiwi, You are probably right about SWAV. I Number sleven 12/08/21 02:56:14 PM
#362495   KIWI, At 71 they said I had a couple antibluechip 12/08/21 02:53:55 PM
#362494   The Jan 21 2022 $10 puts are bid The Canes 12/08/21 02:40:21 PM
#362493   N7. the recent interview I cited in a Whalatane 12/08/21 02:36:33 PM
#362492   Dave Lipitor is easier to take than Whalatane 12/08/21 02:27:19 PM
#362491   Thanks jfmcrr, antibluechip 12/08/21 02:15:45 PM
#362490   N7. along the lines of near term Whalatane 12/08/21 02:15:18 PM
#362488   ziploc, maybe that's why the Jan 21 $10 lizzy241 12/08/21 01:22:16 PM
#362487   genius.png I... it's... beautiful Meowza 12/08/21 01:19:48 PM
#362486   jfmcrr, That is a very interesting post - jasbg 12/08/21 01:18:56 PM
#362485   May 1, 2019 — "Dorsey Represents Eddingpharm in ziploc_1 12/08/21 01:13:31 PM
PostSubject
Consent Preferences